Press Release Details 5.23.0

View all news

CBD Life Sciences, Inc. (CBDL) Launches CBD Home Delivery Service Across Phoenix-Scottsdale Metro Area


SCOTTSDALE, AZ / ACCESSWIRE / February 7, 2023 / Today CBD Life Sciences (CBDL), through its wholly owned subsidiary, LBC Bioscience Inc., announces today that the company is beginning to offer same day Home Delivery for all CBD Products across the Phoenix-Scottsdale Metro Area.

LBC Bioscience Inc. is currently dominating the CBD Industry in Arizona and is proud to start offering Same Day Home Delivery to local residents & beloved loyal customers! Customers will have the choice of Home Delivery by placing an order by phone or via when checking out. President & CEO Lisa Nelson states, "This is the step in the right direction, and we will continue to stretch to other areas as we expand and open up more manufacturing facilities around the United States." Lisa Nelson also stated, "This will be a convenient & quick reliable service in a movement to assist our elderly customers that need it the most!" When it comes to CBD, nothing provides more versatility than having your order delivered right to your doorstep and cannabis enthusiasts are willing to pay for it. CBD delivery benefits both retailers and customers. Besides the logistics and safety benefits, home delivery provides a stress-free, faster, and more convenient operation that's here to stay. The service will be for all CBD Products including pets & will be available starting today. In other news, LBC Bioscience Inc. has finished creating its 2023 Mass Distributor Wholesale Catalog for big retailers and will be available as soon as possible. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.

The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to receive help from CBD. More news to come!


LBC BIOSCIENCE'S Online Emporium

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its 100 MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top-selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Become a Distributor

Large Selection of Products (over 50 items and growing)

100% USA Made Products "organic & kosher."

All Products are THC-FREE (they contain 0.00% THC)

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:

LBC Bioscience Inc's Main Website at




About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and bought on the Company's website at Contact:

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


SOURCE: CBD Life Sciences Inc.

View source version on

View all news